NSE: RUBICON · 19 November 2026
- Rubicon Research Ltd. shares rose 3.86% on Wednesday, trading near the upper end of their intraday range. The stock opened at ₹1,669.00 and reached a day's high of ₹1,745.10 before settling at ₹1,722.30.
- Rubicon Research submitted the detailed transcript of its earnings call for the second quarter ended September 30, 2026. This follows the initial financial results announcement and audio recording made available to the exchange in early November 2026.
- Trading volume was 0.75 times the 20-day average daily volume.
Why is Rubicon Research share price rising on 19 November 2026?
Rubicon Research Ltd. shares rose 3.86% on Wednesday, trading near the upper end of their intraday range. The stock opened at ₹1,669.00 and reached a day's high of ₹1,745.10 before settling at ₹1,722.30.
The broader market and sectoral benchmarks posted positive gains during the session, with the Nifty rising 1.14% and the Nifty Pharma sector index advancing 0.61%. Rubicon Research outperformed both the broader index and its sectoral peers, extending its recent 20-day return momentum to 19.23% following a brief consolidation phase over the prior two trading sessions.
While no single same-day exchange filing directly triggered today's price action, recent corporate updates include the company's Q2 FY 2026-27 financial results and earnings call transcript submitted in November 2026, alongside an ongoing update regarding the scheme of merger with KIA Health Tech Pvt Ltd.
1.53 lakh shares traded by 19 November 2026 · 03:30 PM IST. This compares with a 20-day average daily volume of 2.02 lakh shares (0.75 times). The five-day average daily volume was 83,729 shares. Separately, the NSE report for 19 November 2026 showed 87,779 shares delivered, representing 57.55% of that day’s traded volume. The same report recorded 15,786 trades.
Today's upward move lacks an explicit same-day corporate catalyst. The price increase is accompanied by above-average 5-day volume and aligns with positive momentum across pharmaceutical equities and broader market indices.
Latest Company Developments
Rubicon Research submitted the detailed transcript of its earnings call for the second quarter ended September 30, 2026. This follows the initial financial results announcement and audio recording made available to the exchange in early November 2026.
Earnings updates provide essential visibility into revenue growth, operating margins, and management guidance.
The company filed an update regarding the ongoing scheme of merger between Rubicon Research Ltd and KIA Health Tech Pvt Ltd under Regulation 30 of SEBI Listing Regulations.
Corporate restructuring and merger updates are closely monitored by investors for potential impacts on corporate structure and operational synergies.
Audio Recording of the Earnings call held for Q2 ended September 30, 2026.
Ownership & Transaction Activity
Mutual Fund Holdings
Mutual funds held 13.78% on 30 September 2026. This compares with 7.23% on 30 June 2026, a change of +6.55 percentage points.
The filing reported 20 MF/UTI holders.
Historical Bulk / Block Deals
What to Watch Next
- Execution progress on the scheme of merger with KIA Health Tech Pvt Ltd
- Delivery volume trends and sustenance above the 20-day average volume of 0.75x
- Management commentary and updates following the Q2 FY 2026-27 earnings disclosures
- Price action relative to the 52-week high of ₹1,899.00
Other Dated Coverage
More Rubicon Research news and dated analysis →
Frequently Asked Questions
What is the latest Rubicon Research company news?
Rubicon Research submitted the detailed transcript of its earnings call for the second quarter ended September 30, 2026. This follows the initial financial results announcement and audio recording made available to the exchange in early November 2026.
How strong was Rubicon Research’s trading volume?
1.53 lakh shares traded, 0.75 times the 20-day average daily volume. The price and volume data are dated 19 November 2026 · 03:30 PM IST.
Do the mutual-fund figures show buying today?
They show holdings on 30 September 2026. Quarterly holdings do not identify purchases made on the article date.
Research & analysis: WittyTrades Research Desk
Reviewed by: Mohanish Sanghavi — SEBI Registered Research Analyst
Disclaimer: Investments in securities markets are subject to market risks. Registration with SEBI and NISM certification do not guarantee performance or returns. This article is for information and education, not personalised investment advice or a recommendation to buy, sell or hold.
